ArticleAlzheimer's research & therapy2024

Histone deacetylase inhibitors VPA and WT161 ameliorate the pathological features and cognitive impairments of the APP/PS1 Alzheimer's disease mouse model by regulating the expression of APP secretases.

Miaomiao Zhang et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.